中文版HOME

Day One:  Oct. 27th

■Overview and Trends of Biopharma Industry

■Innovative Biologics Development

■Quality Control & Biomanufacturing Strategies

■1-2-1 Meeting

Day Two:  Oct. 28th

■Regulatory and Development Strategies for Biosimilars

■Innovative Antibody Discovery Platform

■Optimizing Strategies for Upstream&Downstream Bioprocessing

■Tech Transfer & Facility Design

■1-2-1 Meeting


 

>>Add into Calendar

会议酒店:上海东锦江希尔顿逸林酒店

地址:上海浦东新区杨高南路889号(近蓝村路)

电话:021-50504888

The 4th Annual

BioChina International Summit 2015

BioChina International 2015 Summit is a leading partnering and networking platform for bio industry in China and other parts of the world. Here, you will learn how to do bio business in China and find numerous partnering opportunities no matter you are a start-up biotech, a MNC, an investor, or a new comer.  The event aims to promote the communication and collaboration between China and global bio industry so as to accelerate fast and healthy development of China biopharma industry.

Hot Topics
  • Global biopharma development:progress and trend
  • Strategies of MNCs in China
  • Best partnering models between local pharma and MNCs
  • Deep analysis of newly-released guideline for biosimilar development and evaluation
  • Leading strategies on pre-clinical and clinical development for Biosimilars
  • Investment and Financing in China Biopharma industry
  • Partnering practices in China vaccine industry
  • Challenges and opportunities for immunotherapy development in China
  •  Successful stories and best practices to develop biologics in China
  • Capacity and capability building in biologic production technology
  • Antibody discovery technologies
  • Immunotherapy/ADC/Biospecific development progress
  • Leading technologies on bioprocessing
Previous Speaker:
Michael Yu
President and Chief Executive Officer
Joe Zhou
CEO
Genor BioPharma
Changlin Dou
Chief Technology Officer
Luye Pharma Group
Bai Xianhong
President & General Manager
Biotech Pharmaceutical
Zhu Xun
Professor/Senior Advisor
Jilin University/New Horizon Capital
David Fu
Partner
Global Law Office, China
Luo Shun
President
Jianshun Biosciences
Jun Wang
Market Manager, Life Sciences division
Pall Filter (Beijing)
Sun Le
CEO & President
AbMax Biotechnology
Baoping Wang
President
Novo Nordisk Reserch Center China
Boyan Zhang
CSO & VP
Mab-Works
Bo Xu
Head of GMP Biologics Supply
Boehringer Ingelheim Biopharm China
Huifang Liu
vice president
Beijing Mab-works Corporation
Hai Pan
Vice President of R&D
Kawin Technology
Bin Shen
Vice president
Huasun Biotech
Ning Zhang
Associate Director, PDMS, China R&D,
Janssen Pharmaceuticals, Shanghai, China
Yong-jiang Hei
Executive Medical Director
Amgen China
Xingong Jiang
Engineering Director
Pfizer Global Supply Dalian Site
Hang Zhou
Associate Director of Cell Culture Development
WuXi AppTec
Jiali Luo
Vice President
BoerheringerIngelheim China
Jin Liu
President
Yisheng Bio
Who Should Attend?

The event will attract an audience from :


■  Biopharmaceuticals
■  Biotechs
■  Academia/NGOs
■  Government authority
■  CROs and CMOs
■  Academics, Research Institutes
■  NGOs and Government
■  Bioprocessing technology and solution provider
■  Cell culture companies
■  Venture Capitalist and investors
■  Consulting and law firms

 

 

President, Vice President and Chief Executives, Scientists, Directors, (Deputy)General Managers and Head of :


■  Research and Development
■  External Research/Partnering, AllianceImmunology
■  Business Development

■  Biopharmaceutical Research
■  Antibody Discovery

■  Regulatory affairs
■  Preclinical/clinical reserch and development
■  Biosimilars
■  Licensing
■  Marketing
■  Chief technology officers
■  Process development
■  Manufacturing
■  External manufacturing/manfacturing network
■  Quality assurance/quality control
■  Technical operations
■  Cell culture

Media Partners
Organizers
Supporters
Sponsors


Organizers:Shine Media International
For more information ,please contact constance shen at 86-021-52428147 or send email to constance.shen@shinemediaworld.com